AVL-292

AVL-292
Item number Size Datasheet Manual SDS Delivery time Quantity Price
LKT-A8644.1 1 mg -

3 - 8 business days*

90.00€
LKT-A8644.5 5 mg -

3 - 8 business days*

229.00€
LKT-A8644.25 25 mg -

3 - 8 business days*

658.00€
 
AVL-292 is a Bruton's tyrosine kinase (BTK) inhibitor that exhibits anticancer chemotherapeutic... more
Product information "AVL-292"
AVL-292 is a Bruton's tyrosine kinase (BTK) inhibitor that exhibits anticancer chemotherapeutic activities. AVL-292 is in clinical development as a potential treatment for B-cell-related disorders such as chronic lymphocytic leukemia (CLL).
Keywords: CC-292
Supplier: LKT Laboratories
Supplier-Nr: A8644

Properties

Application: BTK inhibitor
MW: 423.44 D
Purity: >98%
Format: Solid

Database Information

CAS : 1202757-89-8| Matching products
KEGG ID : K07370 | Matching products

Handling & Safety

Storage: +20°C
Shipping: +20°C (International: +20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "AVL-292"
Write a review
or to review a product.
Viewed